FR2432525A1 - Nouveaux derives de la doxorubicine, leur preparation et les compositions qui les contiennent - Google Patents

Nouveaux derives de la doxorubicine, leur preparation et les compositions qui les contiennent

Info

Publication number
FR2432525A1
FR2432525A1 FR7919890A FR7919890A FR2432525A1 FR 2432525 A1 FR2432525 A1 FR 2432525A1 FR 7919890 A FR7919890 A FR 7919890A FR 7919890 A FR7919890 A FR 7919890A FR 2432525 A1 FR2432525 A1 FR 2432525A1
Authority
FR
France
Prior art keywords
preparation
compositions containing
doxorubicin derivatives
derivatives
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7919890A
Other languages
English (en)
French (fr)
Other versions
FR2432525B1 (https=
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INST INT PATHOLOGIE CELLULAIRE
Original Assignee
INST INT PATHOLOGIE CELLULAIRE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST INT PATHOLOGIE CELLULAIRE filed Critical INST INT PATHOLOGIE CELLULAIRE
Publication of FR2432525A1 publication Critical patent/FR2432525A1/fr
Application granted granted Critical
Publication of FR2432525B1 publication Critical patent/FR2432525B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FR7919890A 1978-08-03 1979-08-02 Nouveaux derives de la doxorubicine, leur preparation et les compositions qui les contiennent Granted FR2432525A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE869485 1978-08-03

Publications (2)

Publication Number Publication Date
FR2432525A1 true FR2432525A1 (fr) 1980-02-29
FR2432525B1 FR2432525B1 (https=) 1983-12-02

Family

ID=3861689

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7919890A Granted FR2432525A1 (fr) 1978-08-03 1979-08-02 Nouveaux derives de la doxorubicine, leur preparation et les compositions qui les contiennent

Country Status (6)

Country Link
US (1) US4296105A (https=)
JP (1) JPS5522697A (https=)
CA (1) CA1115694A (https=)
FR (1) FR2432525A1 (https=)
GB (1) GB2027024B (https=)
NL (1) NL191150C (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107285A (en) * 1985-08-02 2000-08-22 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124318A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.R.L. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5977082A (en) 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5866679A (en) * 1994-06-28 1999-02-02 Merck & Co., Inc. Peptides
US5599686A (en) * 1994-06-28 1997-02-04 Merck & Co., Inc. Peptides
US6143864A (en) * 1994-06-28 2000-11-07 Merck & Co., Inc. Peptides
JP4157600B2 (ja) * 1994-08-19 2008-10-01 ラ レフィオン バロンネ 化合物、製剤用組成物及びこれらを含む診断装置とこれらの利用
BE1008581A3 (fr) * 1994-08-19 1996-06-04 Wallone Region Prodrogues, composition pharmaceutique les comprenant et leur utilisation.
JP2543434Y2 (ja) * 1996-04-15 1997-08-06 マツダ株式会社 エンジンの排気管構造
US5998362A (en) * 1996-09-12 1999-12-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US5948750A (en) * 1996-10-30 1999-09-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US6391305B1 (en) 1997-09-10 2002-05-21 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US20040081659A1 (en) * 1997-12-02 2004-04-29 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
ZA9810974B (en) * 1997-12-02 1999-06-03 Merck & Co Inc Conjugates useful in the treatment of prostate cancer
HRP20000367A2 (en) * 1997-12-02 2000-12-31 Merck & Co Inc Conjugates useful in the treatment of prostate cancer
US6174858B1 (en) 1998-11-17 2001-01-16 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US7425541B2 (en) 1998-12-11 2008-09-16 Medarex, Inc. Enzyme-cleavable prodrug compounds
WO2001028593A2 (en) 1999-10-19 2001-04-26 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
JP2003512475A (ja) 1999-10-27 2003-04-02 メルク エンド カムパニー インコーポレーテッド 前立腺癌の治療に有用な複合体の塩形態
JP2003513756A (ja) * 1999-11-12 2003-04-15 アンジオテック ファーマシューティカルズ，インコーポレイテッド 放射性治療と細胞周期インヒビターとの組合せの組成物
JP2004510702A (ja) 2000-06-14 2004-04-08 メダレックス，インコーポレイティド イソロイシンを有するプロドラッグ化合物
WO2002015700A1 (en) * 2000-08-24 2002-02-28 Coulter Pharmaceutical, Inc. Prodrugs activated by plasmin and their use in cancer chemotherapy
US20030232760A1 (en) * 2001-09-21 2003-12-18 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US20030216758A1 (en) * 2001-12-28 2003-11-20 Angiotech Pharmaceuticals, Inc. Coated surgical patches
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
EP2075014B9 (en) 2002-05-24 2012-02-01 Angiotech International Ag Compositions and methods for coating medical implants
KR20050084599A (ko) 2002-09-26 2005-08-26 안지오테크 인터내셔날 아게 혈관주위 랩
EP2181704B1 (en) 2002-12-30 2015-05-06 Angiotech International Ag Drug delivery from rapid gelling polymer composition
CA2536192A1 (en) * 2003-11-20 2005-06-09 Angiotech International Ag Soft tissue implants and anti-scarring agents
EP3075247B1 (en) * 2004-02-02 2022-10-12 BioSight Ltd. Conjugates for cancer therapy and diagnosis
AU2005100176A4 (en) * 2005-03-01 2005-04-07 Gym Tv Pty Ltd Garbage bin clip
WO2014160037A2 (en) 2013-03-14 2014-10-02 The Regents Of The University Of California Activatable membrane-interacting peptides and methods of use
US12064445B2 (en) 2015-12-03 2024-08-20 Biosight Ltd. Cytarabine conjugates for cancer therapy
US12071450B2 (en) 2015-12-03 2024-08-27 Biosight Ltd. Salts of conjugates for cancer therapy
BR112018011177A2 (pt) 2015-12-03 2018-11-21 Biosight Ltd conjugados de citarabina para terapia de câncer
US11104698B2 (en) 2015-12-03 2021-08-31 Biosight Ltd. Salts of conjugates for cancer therapy
WO2017094011A1 (en) 2015-12-03 2017-06-08 Biosight Ltd. Salts of conjugates for cancer therapy

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7164M (https=) * 1968-02-22 1969-08-04
FR2430425A1 (fr) * 1978-07-07 1980-02-01 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1578734A (https=) * 1967-11-28 1969-08-22
FI51808C (fi) * 1968-07-15 1977-04-12 Rhone Poulenc Sa Menetelmä uusien kasvainten naftaseenijohdannaisten valmistamiseksi.
GB1500421A (en) * 1975-01-22 1978-02-08 Farmaceutici Italia Optically active anthracyclinones
US4012448A (en) * 1976-01-15 1977-03-15 Stanford Research Institute Synthesis of adriamycin and 7,9-epiadriamycin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7164M (https=) * 1968-02-22 1969-08-04
FR2430425A1 (fr) * 1978-07-07 1980-02-01 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions pharmaceutiques qui les contiennent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107285A (en) * 1985-08-02 2000-08-22 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside

Also Published As

Publication number Publication date
GB2027024B (en) 1983-04-27
NL7905953A (nl) 1980-02-05
CA1115694A (en) 1982-01-05
GB2027024A (en) 1980-02-13
FR2432525B1 (https=) 1983-12-02
JPS6259715B2 (https=) 1987-12-12
JPS5522697A (en) 1980-02-18
NL191150C (nl) 1995-02-16
US4296105A (en) 1981-10-20
NL191150B (nl) 1994-09-16

Similar Documents

Publication Publication Date Title
FR2432525A1 (fr) Nouveaux derives de la doxorubicine, leur preparation et les compositions qui les contiennent
IS1262B6 (is) Ný samsetning efnis
KR900016098A (ko) 카페인산의 유도체 및 이를 함유하는 약제학적 조성물
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
SE8006716L (sv) Cytostatiskt verksamma beredningar, nya isocyanursyraderivat och forfarande for deras framstellning
FR2457278A1 (fr) Utilisation therapeutique de 9-aminoalkylfluorenes
IL69292A (en) Muramyl peptides substituted by 1,2-diacylated-sn-glycero-3-hydroxyphosphoryl,their manufacture and pharmaceutical compositions containing them
FR2361879A2 (fr) Nouvelles 4,5,6,7- tetrahydro-7-oxo (ou hydroxy)benzo (b)thienyl-4-amines utiles notamment comme agents de croissance pour animaux et leur procede de preparation
IL67835A0 (en) Imidazolidine derivatives,their preparation and pharmaceutical compositions containing them
PT77666B (fr) Procede de preparation de nouveaux derives de la nitrosouree
ATE30152T1 (de) 1-methyl-5-nitro-imidazolin-derivate und diese enthaltende therapeutische zusammensetzungen.
SE7708452L (sv) Komposition innehallande en antrakinonforening
ES483271A1 (es) Un metodo para preparar tiofenocarboxamido-alcohil-mercapta-nos
SE7905940L (sv) Nya derivat av daunorubicin, framstellning av desamma och farmaceutiska kompositioner innehallande desamma
FR2412562A1 (fr) Nouveaux derives de 6'-epi-fortimicines a et b utiles notamment comme agents antibacteriens, procede et intermediaires pour leur preparation et composition pharmaceutique les contenant
GB1310779A (en) N-pyridylalkyl-beta-alkoxy-beta-trifluoromethylphenalkylamines
ES8302734A1 (es) Procedimiento para preparar 5'-n-(aminoalquil)-amino-5'-deo-xiadenosina
GB1466411A (en) Sulphur-containing hydroxy aliphatic compounds
GR851995B (https=)
JPS5210218A (en) Preparation of beta-sulfenylacrylamides
FR2452495A1 (fr) 2-epi-fortimicines a et b et leurs derives, utiles notamment comme antibiotiques, et intermediaires pour leur preparation
GB849755A (en) Pharmaceutical preparations comprising ª‡-dialkylamino-propiophenones
SE8303410L (sv) Bensenderivat, forfaranden for framstellning derav och farmaceutiska kompositioner innehallande desamma
ES413743A1 (es) Un procedimiento para la preparacion de compuestos de acidol-alfa-hidrazino-betaf-fenilpropionico.
GB1399992A (en) Compositions for the treatment of drug addiction and alcoholism

Legal Events

Date Code Title Description
ST Notification of lapse